Wockhardt’s CMD Habil Khorakiwala Quits as Company’s Debt Piles Higher

Mumbai-based pharmaceutical major Wockhardt has become the latest victim of piling debt. The company has been referred to the corporate debt restructuring (CDR) mechanism, a system to deal with cases where multiple lenders are involved. In its filing with the Bombay Stock Exchange on Tuesday, the pharma major said that Habil Khorakiwala, currently chairman and … Read more Wockhardt’s CMD Habil Khorakiwala Quits as Company’s Debt Piles Higher

HCC bags Rs 688.06 cr order at Punatsangchhu-l Hydra Electric Project

Hindustan Construction Company Ltd (HCC) has informed BSE that the Company has bagged the prestigious order for Package MC3 of 1200 MW Punatsangchhu-I Hydro Electric Project in Bhutan from Punatsangchhu-I Hydro Electric Project Authority. The Punatsangchhu-I Hydro Electric Project is located on river Punatsangchhu in Wangdue Phodrang Dzongkhag in Western Bhutan. The said project involves … Read more HCC bags Rs 688.06 cr order at Punatsangchhu-l Hydra Electric Project

Brandhouse Retail to roll out 15 new stores as a part of JV with Oviesse

Highlights of the conference call are Brandhouse Retail is the master franchisee for leading domestic brands including Reid & Taylor, Belmonte, Carmichael House and Stephens Brothers and exclusive India franchisee for International luxury brands like Alfred Dunhill. BHRL has been involving in the setting up and managing of over 670 EBO’s (Exclusive Brand Outlets) for … Read more Brandhouse Retail to roll out 15 new stores as a part of JV with Oviesse

IRDA may allow insures to launch Universal Life Policy

The Insurance Regulatory and Development Authority (IRDA) is likely to allow the life insurers to introduce the Universal Life Policy (ULP) which allows the customers to change the policy amount after buying the policy for a different amount. The regulator is currently studying the UK model of this policy which is at the front position … Read more IRDA may allow insures to launch Universal Life Policy

Matrix Laboratories gets first tentative FDA nod for Generic Truvada

Matrix Laboratories has got the first tentative nod from the US Food and Drug Administration (USFDA) under the President’s Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg. The tablets are the generic version of Gilead Sciences Inc.’s Truvada Tablets. The … Read more Matrix Laboratories gets first tentative FDA nod for Generic Truvada